Identification of Staphylococcus aureus Proteins Recognized by the Antibody-Mediated Immune Response to a Biofilm Infection
- 1 June 2006
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 74 (6) , 3415-3426
- https://doi.org/10.1128/iai.00392-06
Abstract
Staphylococcus aureus causes persistent, recurrent infections (e.g., osteomyelitis) by forming biofilms. To survey the antibody-mediated immune response and identify those proteins that are immunogenic in an S. aureus biofilm infection, the tibias of rabbits were infected with methicillin-resistant S. aureus to produce chronic osteomyelitis. Sera were collected prior to infection and at 14, 28, and 42 days postinfection. The sera were used to perform Western blot assays on total protein from biofilm grown in vitro and separated by two-dimensional gel electrophoresis. Those proteins recognized by host antibodies in the harvested sera were identified via matrix-assisted laser desorption ionization-time of flight analysis. Using protein from mechanically disrupted total and fractionated biofilm protein samples, we identified 26 and 22 immunogens, respectively. These included a cell surface-associated beta-lactamase, lipoprotein, lipase, autolysin, and an ABC transporter lipoprotein. Studies were also performed using microarray analyses and confirmed the biofilm-specific up-regulation of most of these genes. Therefore, although the biofilm antigens are recognized by the immune system, the biofilm infection can persist. However, these proteins, when delivered as vaccines, may be important in directing the immune system toward an early and effective antibody-mediated response to prevent chronic S. aureus infections. Previous works have identified S. aureus proteins that are immunogenic during acute infections, such as sepsis. However, this is the first work to identify these immunogens during chronic S. aureus biofilm infections and to simultaneously show the global relationship between the antigens expressed during an in vivo infection and the corresponding in vitro transcriptomic and proteomic gene expression levels.Keywords
This publication has 128 references indexed in Scilit:
- Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigensVaccine, 2005
- Inhibition of Biofilm Formation by Monoclonal Antibodies againstStaphylococcus epidermidisRP62A Accumulation-Associated ProteinClinical and Vaccine Immunology, 2005
- Effects of the Antibiotic Pulvomycin on the Elongation Factor Tu-Dependent Reactions. Comparison with Other AntibioticsBiochemistry, 2004
- Correlation of proteomic and transcriptomic profiles of Staphylococcus aureus during the post-exponential phase of growthJournal of Microbiological Methods, 2004
- Staphylococcus aureusCapsular PolysaccharidesClinical Microbiology Reviews, 2004
- Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureusProceedings of the National Academy of Sciences, 2002
- Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patientsThe Lancet, 2002
- Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 2002
- Human antibody response during sepsis against targets expressed by methicillin resistantStaphylococcus aureusFEMS Immunology & Medical Microbiology, 2000
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976